Embrace the future of gene therapies with ELEVECTA™ producer cell line. Large-scale viral vector manufacturing encounters hurdles like batch variability caused by transient transfection. ELEVECTA™ producer cell line provides the remedy by having all components stably integrated. Production starts simply by adding an induction reagent. This one-step process ensures robustness and scalability for your gene therapy endeavors.
Have questions or want to talk to someone about cell line development services? Contact our team at
ELEVECTA@cytiva.com
